Susquehanna Fundamental Investments, LLC Immatics N.V. Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.81 - $14.38 $172,062 - $228,886	-15,917 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.58 - $15.46 $68,044 - $90,842	5,876 Added 58.52%	15,917 $207,000
Q2 2021 Aug 11, 2021	SELL	$10.43 - $12.81 $65,124 - $79,985	-6,244 Reduced 38.34%	10,041 $117,000
Q1 2021 May 17, 2021	SELL	$10.24 - $14.6 $240,619 - $343,070	-23,498 Reduced 59.07%	16,285 $183,000
Q4 2020 Feb 16, 2021	SELL	$9.67 - $12.05 $31,427 - $39,162	-3,250 Reduced 7.55%	39,783 $429,000
Q3 2020 Nov 16, 2020	BUY	$8.73 - $15.15 $375,678 - $651,949	43,033 New	43,033 $457,000

100

76.8M

571K

210K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $701M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.